Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2017 · 10-Q
Revenue$99.98K$99.98K+156.4% vs Q2 2016 Net Income-$2.57M-$2.57MN/M vs Q2 2016 EPS Diluted-$0.03-$0.03N/M vs Q2 2016 Gross Profit$26,579+14.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$872,376N/M Margins · derivedGross margin26.6%−33.0 pt vs Q2 2016
Operating margin-1466.6%+1696.5 pt vs Q2 2016
Net margin-2574.7%+1704.6 pt vs Q2 2016
ended Jun 30, 2017 · filed Aug 14, 2017 · 45 d after period end